We are live on !
Find out more
Choreo LLC Portfolio holdings
AUM
$9.11B
Turnover
16.81%
1-Year Est. Return
26.3%
This Fund
S&P 500
This Quarter Est. Return
+15.69%
1 Year Est. Return
+26.3%
3 Year Est. Return
+74.73%
5 Year Est. Return
+70.98%
10 Year Est. Return
+244.22%
AUM
$9.11B
AUM Growth
+$968M
(+12%)
Cap. Flow
-$15.1M
Cap. Flow % of AUM
Cap. Flow %
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
30.74%
Holding
1,803
New
190
Increased
690
Reduced
735
Closed
113
Avg Time Held
2.4
years
Top 10 Avg Time Held
5.2
years
Top 20 Avg Time Held
5.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$24.2M |
| 2 |
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$17.5M |
| 3 |
Vanguard Total Bond Market
BND
|
+$16.4M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$10.8M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$31M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$10.8M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$8.85M |
| 4 |
Blackstone
BX
|
+$7.63M |
| 5 |
Bank of America
BAC
|
+$6.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.84% |
| 2 | Technology | 12.19% |
| 3 | Financials | 6.9% |
| 4 | Industrials | 3.9% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1626
FreeCast Inc
CAST
$55.4M
| $76.6K | ﹤0.01% |
11,400
-3,000
| -21% | -$8.84K |
2026 Q1
1 quarter
|
|
1627
Eos Energy Enterprises
EOSE
$630M
| $73.3K | ﹤0.01% |
12,463
+155
| +1% | +$1.08K |
2026 Q1
1 quarter
|
|
1628
Ellington Residential Mortgage REIT
EARN
$136M
| $72.5K | ﹤0.01% |
16,409
+7
| +0% | +$33 |
2023 Q4
10 quarters
|
|
1629
Taysha Gene Therapies
TSHA
$1.29B
| $72.3K | ﹤0.01% |
10,618
+574
| +6% | +$3.4K |
2026 Q1
1 quarter
|
|
1630
VivoPower PLC
VIVO
$77.4M
| $70.3K | ﹤0.01% |
+13,606
| New | +$56.2K |
2026 Q2
0 quarters
|
|
1631
Aurora
AUR
$9.6B
| $68.8K | ﹤0.01% |
+10,092
| New | +$61.7K |
2026 Q2
0 quarters
|
|
|
MIN
1632
Aberdeen Intermediate Income Fund
MIN
$265M
| $66.7K | ﹤0.01% |
4,503
| – | – |
2024 Q2
8 quarters
|
|
1633
Western Asset High Income Fund II
HIX
$301M
| $63.3K | ﹤0.01% |
15,991
-1,453
| -8% | -$5.77K |
2025 Q2
4 quarters
|
|
1634
Peloton Interactive
PTON
$2.36B
| $61K | ﹤0.01% |
10,314
-5,083
| -33% | -$27.4K |
2024 Q2
8 quarters
|
|
1635
JetBlue
JBLU
$992M
| $59.8K | ﹤0.01% |
+10,440
| New | +$53.2K |
2026 Q2
0 quarters
|
|
1636
Iovance Biotherapeutics
IOVA
$6.38B
| $54.9K | ﹤0.01% |
13,197
+128
| +1% | +$486 |
2024 Q2
8 quarters
|
|
1637
Grab
GRAB
$11.4B
| $52.8K | ﹤0.01% |
14,003
-2,297
| -14% | -$8.36K |
2024 Q2
8 quarters
|
|
1638
FTAI Infrastructure
FIP
$300M
| $51.8K | ﹤0.01% |
11,159
-107
| -0.9% | -$533 |
2024 Q2
8 quarters
|
|
1639
Altimmune
ALT
$412M
| $50.8K | ﹤0.01% |
16,709
+18
| +0.1% | +$54 |
2026 Q1
1 quarter
|
|
1640
OKYO Pharma
OKYO
$73.5M
| $49.9K | ﹤0.01% |
+33,255
| New | +$53.3K |
2026 Q2
0 quarters
|
|
1641
Opko Health
OPK
$1.22B
| $47.2K | ﹤0.01% |
31,474
-2,283
| -7% | -$2.91K |
2023 Q4
10 quarters
|
|
1642
Shimmick
SHIM
$95.9M
| $46.9K | ﹤0.01% |
10,272
| – | – |
2024 Q2
8 quarters
|
|
1643
BigBear.ai
BBAI
$1.03B
| $43.3K | ﹤0.01% |
11,796
+1,040
| +10% | +$4.16K |
2025 Q3
3 quarters
|
|
1644
Richtech Robotics
RR
$261M
| $40.6K | ﹤0.01% |
+19,257
| New | +$46.8K |
2026 Q2
0 quarters
|
|
1645
Cerus
CERS
$470M
| $40.1K | ﹤0.01% |
13,749
+2,753
| +25% | +$6.68K |
2026 Q1
1 quarter
|
|
1646
Plug Power
PLUG
$1.93B
| $39K | ﹤0.01% |
14,385
+1,492
| +12% | +$4.69K |
2025 Q2
4 quarters
|
|
1647
Recursion Pharmaceuticals
RXRX
$1.98B
| $37.2K | ﹤0.01% |
10,132
-148
| -1% | -$493 |
2026 Q1
1 quarter
|
|
1648
Palisade Bio
PALI
$232M
| $32.9K | ﹤0.01% |
15,743
| – | – |
2026 Q1
1 quarter
|
|
1649
Wipro
WIT
$20.9B
| $32.5K | ﹤0.01% |
14,433
-2,305
| -14% | -$4.9K |
2024 Q2
8 quarters
|
|
1650
Invesco Senior Income Trust
VVR
$434M
| $32.3K | ﹤0.01% |
+10,759
| New | +$32.9K |
2026 Q2
0 quarters
|
|
Similar funds
Choreo LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Choreo LLC held 1,803 positions worth $9.11B, up 12% from $8.15B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Choreo LLC's Q2 2026 filing shows 190 new, 690 increased, 735 reduced and 113 closed positions. Its largest new stake was Janus Henderson Small Cap Growth Alpha ETF: 56,418 shares worth $5.25M. The largest sale was ExxonMobil, an estimated $31M.
By sector, the portfolio is most concentrated in Miscellaneous at 62% of assets, up from 61% a quarter earlier, followed by Technology and Financials.
- Choreo LLC's largest Q2 2026 buy was Janus Henderson Small Cap Growth Alpha ETF: 56,418 shares worth $5.25M.
- Choreo LLC added most to Dimensional Emerging Markets Core Equity 2 ETF in Q2 2026, an estimated $24.2M increase.
- Choreo LLC's biggest Q2 2026 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $10.8M.
- Choreo LLC fully exited ExxonMobil in Q2 2026, selling an estimated $31M.
- Choreo LLC's ten largest holdings make up 31% of its $9.11B portfolio in Q2 2026.
- Choreo LLC opened 190 new positions and closed 113 in Q2 2026.
- Choreo LLC's portfolio value rose 12% quarter-over-quarter to $9.11B.
Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.